GLPwatch
Amgen
AMGN · GLP-1 products, pipeline, and financials
Approved GLP-1 products (0)
No FDA-approved GLP-1 products from this manufacturer in our data.
Molecules (0)
No GLP-1 molecules attributed to this manufacturer in our data.
Revenue (SEC) SEC EDGAR ↗
| Concept | Period end | Value | Form |
|---|---|---|---|
| Revenue | 2025-12-31 | $36.8B | 10-K |
| Revenue | 2024-12-31 | $33.4B | 10-K |
| Revenue | 2023-12-31 | $28.2B | 10-K |
| Revenue | 2022-12-31 | $26.3B | 10-K |
| Revenue | 2021-12-31 | $26.0B | 10-K |
| Revenue | 2020-12-31 | $25.4B | 10-K |
| Revenue | 2019-12-31 | $23.4B | 10-K |